freespira.com

What It Is

Freespira is an at-home behavioral health treatment solution from Freespira, Inc. It is positioned not as traditional enterprise SaaS, but as a combination of “digital therapeutics + medical device + high-touch service.” The website describes it as the only FDA-cleared, drug-free treatment that can be used at home to reduce or stop panic attacks and PTSD symptoms, serving individuals, veterans, health plans, healthcare providers, and self-insured employers.

Core Capabilities

The treatment program lasts 28 days, with users completing two 17-minute sessions each day. The system includes a compact breathing sensor and a tablet app that provide real-time feedback on breathing patterns, helping users regulate breathing differences related to hyperventilation and CO₂ sensitivity. Each patient is also matched with a dedicated Care Specialist, who provides guidance, progress monitoring, and answers questions through weekly online check-ins. It can be used alongside medication or talk therapy, rather than requiring users to replace existing treatment.

Pricing and Coverage

The website does not publish standard pricing. Costs mainly depend on insurance, health plan, employer, or VA coverage: some eligible members may use it at no additional cost, while some plans may involve a cost share. Veterans may receive coverage through a VA referral. If insurance does not cover it, users can pay with an HSA/FSA or use an interest-free payment plan.

Pros and Cons

Its strengths include FDA clearance, clear clinical-validation messaging, a standardized usage process, and the combination of real-time sensor feedback with dedicated human support, which clearly differentiates it from ordinary breathing-exercise apps. For health plans, the website also highlights the potential to reduce total healthcare costs, emergency room costs, and pharmacy costs. Limitations include non-transparent pricing and a scope focused on panic attacks, panic disorder, and PTSD; it is not suitable for pregnant people or those with COPD. The text also does not disclose details such as APIs, enterprise dashboards, third-party system integrations, or security information like HIPAA/SOC 2.

Who It’s For and Access From China

It is better suited for compliant users within U.S. health insurance, VA, and employer health benefits systems, as well as patients looking to supplement their care with a drug-free intervention. The main text does not state whether users in China can access it directly, receive device shipping, obtain remote care, or get local medical compliance support, so access and usability in China remain unknown.